ҹ1000

Instant Expert: AIDS – What works?

We must factor in politics, economics and people's behaviour as well as medicine in the fight against HIV, says epidemiologist Elizabeth Pisani
There are behavioural, political and economical aspects to consider
There are behavioural, political and economical aspects to consider
(Image: Peter Parks/Getty)

Read more:Instant Expert: HIV

For years the public health establishment has pontificated about “evidence-based” approaches to HIV prevention; we should only do what has been proven to work. The trouble is that things that succeed in careful scientific studies can fail miserably when translated into real life.

Medical science gives us evidence about what works technically. But we must also consider evidence about how prepared people are to change their behaviour. We need to factor in politics – what we can sell to governments and communities. And we mustn’t forget economics: what’s affordable, and what is not.

When considering a new intervention, we often cherry-pick the evidence that best confirms our own convictions. In assessing abstinence, religious leaders point to the medical science: no sex equals no sexually transmitted infections. Public health doctors, on the other hand, point to the behavioural science: promoting abstinence does not equal no sex.

When it comes to condoms, doctors cling on to medical studies showing they stop transmission of HIV and ignore the behavioural studies that show that condoms often fail because, except in commercial sex, people prefer not to use them.

No amount of evidence will make a programme work if, because of the politics, you can’t get it up and running. Needle exchange programmes, for example, are very effective at cutting HIV among drug users but they are often unpopular with voters and therefore politicians.

“Needle exchange schemes are a highly cost-effective way of slashing HIV rates among drug users”

Another case in point is early antiviral drug treatment for people who are still healthy. While not necessary for their own health, the drugs cut the risk of them passing on the virus to their sexual partners. The evidence suggests this strategy works, at least in a tightly controlled research setting. But in a world already straining to afford drugs for people who have clinical AIDS, how can we afford treatment for the much bigger numbers who are HIV-positive but not yet ill?

Obviously, any prevention approach must work biologically. But we need to spend more time understanding how behaviour, politics and economics undermine or contribute to success. HIV prevention can only succeed on any major scale if it works on all four levels.

Elizabeth Pisani

Elizabeth Pisani has a PhD in infectious disease epidemiology and has spent the last 15 years working on HIV surveillance and prevention for the UN and other international organisations around the globe. Her account of the underbelly of the AIDS industry, The Wisdom of Whores: Bureaucrats, brothels and the business of AIDS, was published by Granta in 2008.

Recommended reading

The Invisible Cure: Why we are losing the fight against AIDS in Africa by Helen Epstein (Farrar, Straus & Giroux, 2007)

“Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand” by Supachai Rerks-Ngarm et al., New England Journal of Medicine, vol 361, p 2209

“Treating our way out of the HIV pandemic: could we, would we, should we?” by Geoffrey Garnett and Rebecca Baggaley, The Lancet, vol 373, p 9

“Prevention of HIV-1 infection with early antiretroviral therapy” by Myron Cohen, The New England Journal of Medicine, vol 365, p 493

WEBSITES

UN Global Report on the AIDS

Elizabeth Pisani’s

HIV Vaccine Trials Network

Microbicides Trials Network

AVAC HIV Prevention Network